Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2019; 30(13): 1565-1572
DOI: 10.1055/s-0039-1690098
DOI: 10.1055/s-0039-1690098
letter
Et3N-Promoted Tandem Cyclization of Bromomaleimides with Active Methylene Compounds: An Efficient Synthesis of cis-3,4-Dihydropyrrolidine-2,5-diones
Financial support from the Center of Analysis & Measurement, Zhejiang University of Technology is greatly appreciated.Further Information
Publication History
Received: 27 April 2019
Accepted after revision: 25 May 2019
Publication Date:
03 July 2019 (online)
Abstract
The Et3N-promoted tandem cyclization of bromomaleimides with active methylene compounds is presented, providing an efficient method for the synthesis of cis-3,4-dihydropyrrolidine-2,5-diones in moderate to good yields under mild conditions.
Key words
Michael addition - tandem reaction - bromomaleimides - cis-3,4-dihydropyrrolidine-2,5-dionesSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0039-1690098.
- Supporting Information
-
References and Notes
- 1a Abell AD, Oldham MD. J. Org. Chem. 1997; 62: 1509
- 1b Barker D, Lin DH. S, Carland JE, Chu CP. Y, Chebib M, Brimble MA, Savage GP, McLeod MD. Bioorg. Med. Chem. 2005; 13: 4565
- 1c de Figueiredo RM, Voith M, Fröhlich R, Christmann M. Synlett 2007; 391
- 2a Peter MG, Snatzke G, Snatzke F, Nagarajan KN, Schmid H. Helv. Chim. Acta 1974; 57: 32
- 2b Bochis RJ, Fisher MH. Tetrahedron Lett. 1968; 9: 1971
- 3a Cheng CF, Lai ZC, Lee YJ. Tetrahedron 2008; 64: 4347
- 3b Tseng TH, Chuang SK, Hua CC, Chang CF, Huang YC, Lin CW, Lee YJ. Tetrahedron 2010; 66: 1335
- 4a Hargreaves MK, Pritchard JG, Dave HR. Chem. Rev. 1970; 70: 439
- 4b Kamitori Y, Hojo M, Masuda R, Kimura T, Yoshida T. J. Org. Chem. 1986; 51: 1427
- 4c Rad-Moghadam K, Kheyrkhah L. Synth. Commun. 2009; 39: 2108
- 4d Luzzio FA. Sci. Synth. 2005; 21: 259
- 4e Reddy PY, Kondo S, Toru T, Ueno Y. J. Org. Chem. 1997; 62: 2652
- 5 Wu QY, Jiang LL, Zuo Y, Wang ZF, Xi Z, Yang GF. Chem. Biol. Drug Des. 2014; 84: 431
- 6a Briere JF, Charpentier P, Dupas G, Queguiner G, Bourguignon J. Tetrahedron 1997; 53: 2075
- 6b Villa Gonzalez S, Carlsen P. Eur. J. Org. Chem. 2007; 3495
- 7a Groutas WC, Brubaker MJ, Stanga MA, Castrisos JC, Crowley JP, Schatz EJ. J. Med. Chem. 1989; 32: 1607
- 7b Hudkins RL, DeHaven-Hudkins DL, Doukas P. Bioorg. Med. Chem. Lett. 1997; 7: 979
- 7c Tomlinson A, Danks TN, Heyes DM. Langmuir 1997; 13: 5881
- 7d Obsnika J, Zejec A, Karolak-Wojciechowska J. Il Farmaco 1999; 54: 423
- 7e Brace NO, Mull SG. J. Fluorine Chem. 2006; 127: 108
- 7f Kaminski K, Obniska J. Bioorg. Med. Chem. 2008; 16: 4921
- 7g Kaminski K, Obniska J, Dybala M. Eur. J. Med. Chem. 2008; 43: 53
- 7h Barker MD, Dixon RA, Jones S, Marsh BJ. Chem. Commun. 2008; 2218
- 7i Obniska J, Kaminski K, Skrzynska D, Pichor J. Eur. J. Med. Chem. 2009; 44: 2224
- 8a Kolyamshin OA, Danilov VA. Russ. J. Org. Chem. 2004; 40: 982
- 8b Jeschke P, Harder A, Etzel W, Gau W, Göhrt A, Benet-Buchholz J, Thielking G. Bioorg. Med. Chem. Lett. 2005; 15: 2375
- 8c Shintani R, Duan WL, Nagano T, Okada A, Hayashi T. Angew. Chem. Int. Ed. 2005; 44: 4611; Angew. Chem. 2005, 117, 4687
- 8d Shintani R, Duan WL, Hayashi T. J. Am. Chem. Soc. 2006; 128: 5628
- 8e Iyer PS, Malley MM. O, Lucas MC. Tetrahedron Lett. 2007; 48: 4413
- 9a Domingo LR, Aurell MJ, Arno M. Tetrahedron 2009; 65: 3432
- 9b Li GQ, Li Y, Dai LX, You SL. Adv. Synth. Catal. 2008; 350: 12588
- 9c Li GQ, Li Y, Dai LX, You SL. Org. Lett. 2007; 9: 3519
- 9d Alcaide B, Almendros P, Cabrero G, Ruiz MP. Chem. Commun. 2007; 4788
- 10a Driller KM, Klein H, Jackstell R, Beller M. Angew. Chem. Int. Ed. 2009; 48: 6041 ; Angew. Chem. 2009, 121, 6157
- 10b Prateeptongkum S, Driller KM, Jackstell R, Spannenberg A, Beller M. Chem. Eur. J. 2010; 16: 9606
- 10c Liu H, Lau GP. S, Dyson PJ. J. Org. Chem. 2015; 80: 386
- 11 Zhang J, Senthilkumar M, Ghosh SC, Hong SH. Angew. Chem. Int. Ed. 2010; 122: 6535
- 12a Huang X, Chen W, Zhou H. Synlett 2004; 329
- 12b Chen W, Cui J, Zhu Y, Hu X, Mo W. J. Org. Chem. 2012; 77: 1585
- 12c Chen W, Li H, Gu X, Zhu Y. Synlett 2015; 785
- 12d Chen W, Jin L, Zhu Y, Cao X, Zheng L, Mo W. Synlett 2013; 1856
- 12e Chen W, Li J, Zhu Y, Ye L, Hu W, Mo W. ARKIVOC 2011; (ix): 381
- 13 Compounds cis-c; General ProcedureTo a stirred solution of bromomaleimide a (0.3 mmol) and 1,3-dicarbonyl compound b (0.33 mmol) in THF (5 mL) was added Et3N (0.5 mL) and the reaction mixture was stirred at room temperature for 2 h. The solvent was evaporated under reduced pressure and the residue purified by silica gel column chromatography (PE–EtOAc, 3:1) to afford the product cis-c. cis-2-Benzyl-6,6-dimethyl-5,6,7,8b-tetrahydro-1H-benzofuro[2,3-c]pyrrole-1,3,8(2H,3aH)-trione (cis-c1)IR (KBr): 2961, 2924, 2869, 1786, 1705, 1629, 1393, 1340, 1212, 1177 cm–1; 1H NMR (500 MHz, CDCl3): δ = 7.33–7.31 (m, 2 H), 7.28–7.25 (m, 3 H), 5.44 (d, J = 8.75 Hz, 1 H), 4.64 (s, 2 H), 4.33 (d, J = 8.75 Hz, 1 H), 2.34 (d, J = 1.25 Hz, 2 H), 2.25 (d, J = 16.25 Hz, 1 H), 2.21 (d, J = 16.25 Hz, 1 H), 1.08 (s, 3 H), 0.99 (s, 3 H); 13C NMR (125 MHz, CDCl3): δ = 192.48, 176.90, 172.54, 171.50, 134.94, 128.81, 128.63, 128.12, 109.39, 81.77, 51.03, 46.06, 42.66, 37.55, 34.02, 28.36, 28.28; HRMS (ESI): m/z [M + Na]+ calcd for C19H19NO4Na: 348.1206; found: 348.1213.
- 14 The cis-stereochemistry was based on the same chemical shifts of H-3 and H-4 and of C-3 and C-4, as well as by considering the adjacent dihydropyrrolidine-2,5-dione ring and the fact that the rigid structure of the three-membered ring stopped rotation or distortion, which led to only the cis-configuration.
- 15 Compounds cis-h; General Procedure A mixture of bromomaleimide a (0.3 mmol), active methylene compound g (0.33 mmol), TBAB (5 mol%), Et3N (0.5 mL) and THF (5 mL) was stirred at room temperature for 3 h. The solvent was evaporated under reduced pressure and H2O was added. The aqueous layer was extracted with EtOAc (3 × 20 mL) and the combined organic layers washed with brine and dried over MgSO4. The solvent was removed in vacuo and the residue purified by column chromatography (PE–EtOAc, 2:1) to give the product cis-h. cis -Ethyl 3-benzyl-6-cyano-2,4-dioxo-3-azabicyclo[3.1.0] hexane-6-carboxylate ( cis -h1) IR (KBr): 3081, 2984, 2248, 1788, 1751, 1710, 1606, 1497, 1393, 1277, 1227, 1165 cm–1; 1H NMR (500 MHz, CDCl3): δ = 7.40–7.38 (m, 2 H), 7.33–7.30 (m, 3 H), 4.60 (s, 2 H), 4.33 (q, J = 6.75 Hz, 2 H), 3.25 (s, 2 H), 1.37 (t, J = 6.40 Hz, 3 H); 13C NMR (125 MHz, CDCl3): δ = 167.99, 162.36, 134.53, 129.12, 128.64, 128.27, 112.07, 64.59, 43.09, 32.66, 30.23, 13.85; HRMS (ESI): m/z [M + Na]+ calcd for C16H14N2O4Na: 321.0846; found: 321.0841.
- 16 The amount of Et3N could lead to a change in the reaction yield based on the conditions tested (see Table 1, entries 6–8). Therefore, we think Et3N may have some solvent effect in the reaction besides serving as a base.
- 17 At present, the reason for the formation of cis products is not clear. However, we think that the reason may be due to the effects of the adjacent dihydropyrrolidine-2,5-dione ring and the relative rigidity of the double bonds of the enol anion, or the potential that the three-membered ring stopped its rotation or distortion, which led to subsequent intramolecular nucleophilic attack only occurring on the same side of the ring and thus leading to the cis-isomer.
- 18a Rankin GA, Anestis DK, Valentovic MA, Sun H, Triest WE. Toxicology 2007; 240: 38
- 18b Maser H, Pissiotas G, Brunner HG, Bohner B, Baumann M. US Patent 4804400, 1989
- 18c Xu GQ, Guo P, Zhang C, He QJ, Yang B, Hu YZ. Chem. Pharm. Bull. 2007; 55: 1302
- 18d Liu HW, Walsh CT. In The Chemistry of the Cyclopropyl Group, Vol. 2. Rappoport Z. John Wiley & Sons; New York: 1987: 959